("Lift" or the "Company")
Final Audited Results to
Chairman's Statement
It gives me great pleasure to present this year's Chairman's Statement for
Miriad: A
Our core investment, Miriad, continues to provide solid financial performance and cash generation. Miriad, which trades as Zak's Traders Café, has cemented its reputation as one of the
During the year, Miriad delivered a positive net cash inflow of
Zak is recognized as a market leader in providing valuable content and distribution for corporate clients. Zak continues to provide insights on
Services Offered by Zak's Traders Café:
· Daily RNS Hot List - Highlights significant regulatory news from companies.
· Daily Bulletin Heroes - 6 days a week technical analysis of the best charting set ups in the small cap space, plus a review of the best recent share price winners.
· Week in Small Caps - Weekly roundup of developments in small-cap stocks.
· Daily US Chart Breakers - Focused analysis on key US stocks making notable movements.
The Company retains a legacy investment in
Board Appointments
Following the period end, we strengthened the Board with the appointments of David Richards MBE and
Strategy and Outlook
The Company now stands at the intersection of financial media and artificial intelligence, two complementary sectors that together offer both stability and extraordinary growth potential. Miriad provides reliable cash flow and brand strength, while exciting technology businesses offers exponential upside as adoption accelerates across every major industry.
Our goal is simple: to back exceptional founders, build scalable companies and create lasting value for shareholders.
I would like to take this opportunity to thank my fellow directors, our management team and our shareholders for their continued trust and support.
David Richards MBE
Non-Executive Chairman
Enquiries:
|
|
|
|
David Richards MBE - Executive Chairman |
via Oberon |
|
|
|
|
|
+44 (0) 203 179 5300 |
For more information please visit: www.liftgv.com
Consolidated and Company Statement of Financial Position
As of
|
|
|
Group |
Company |
||||
|
|
Year ended £ |
Year ended £ |
Year ended £ |
Year ended £ |
|
||
|
Non-Current Assets |
|
|
|
|
|
||
|
Intangible assets |
197,280 |
252,870 |
- |
- |
|
||
|
Investment in subsidiaries |
- |
- |
368,507 |
368,507 |
|
||
|
|
198,114 |
69,881 |
181,191 |
68,420 |
|
||
|
Total non-current assets |
395,394 |
322,751 |
549,698 |
436,927 |
|
||
|
Current Assets |
|
|
|
|
|
||
|
Trade and other receivables |
103,393 |
98,075 |
56,043 |
58,498 |
|
||
|
Financial assets - Fair value through profit and loss |
180,167 |
- |
180,167 |
- |
|
||
|
Cash and cash equivalents |
195,525 |
163,220 |
12,304 |
37,998 |
|
||
|
Total current assets |
479,085 |
261,295 |
248,514 |
96,496 |
|
||
|
Total Assets |
874,479 |
584,046 |
798,212 |
533,423 |
|
||
|
Current Liabilities |
|
|
|
|
|
||
|
Trade and other payables |
148,140 |
108,014 |
119,314 |
64,412 |
|
||
|
Contract liabilities |
229,723 |
12,251 |
- |
- |
|
||
|
Financial liability - Fair value through profit and loss |
60,056 |
- |
60,056 |
- |
|
||
|
Total current liabilities |
437,919 |
120,265 |
179,370 |
64,412 |
|
||
|
Non-current Liabilities |
|
|
|
|
|
||
|
Borrowings |
- |
- |
280,202 |
- |
|
||
|
Total non-current liabilities |
- |
- |
280,202 |
- |
|
||
|
Total Liabilities |
437,919 |
120,265 |
459,572 |
64,412 |
|
||
|
Net Assets |
436,560 |
463,781 |
338,640 |
469,011 |
|
||
|
Equity attributable to owners of the Parent |
|
|
|
|
|
||
|
Share capital |
957,100 |
957,100 |
957,100 |
957,100 |
|
||
|
Share premium |
1,225,507 |
1,225,507 |
1,225,507 |
1,225,507 |
|
||
|
Other reserves |
154,624 |
181,540 |
154,624 |
181,540 |
|
||
|
Accumulated losses |
(1,900,671) |
(1,900,366) |
(1,998,591) |
(1,895,136) |
|
||
|
Total Equity |
436,560 |
463,781 |
338,640 |
469,011 |
|
||
Consolidated Statement of Comprehensive Income
Year ended
|
Continuing Operations |
For the year ended £ |
For the period ended £ |
|
Revenue |
280,733 |
476,506 |
|
Administration expenses |
(358,759) |
(532,619) |
|
Impairment loss of trade receivable |
(12,700) |
(102,933) |
|
Other gains/(losses) |
10,599 |
(4,100) |
|
Operating loss |
(80,127) |
(163,146) |
|
Fair value gains/(losses) on financial assets at fair value through profit and loss |
180,167 |
(750,000) |
|
Fair value losses on financial liabilities at fair value through profit and loss |
(60,056) |
- |
|
Net fair value losses on equity investments |
(67,355) |
(63,006) |
|
Loss before taxation |
(27,371) |
(976,152) |
|
Corporation tax |
150 |
(10,135) |
|
Loss for the year from continuing operations |
(27,221) |
(986,287) |
|
Loss attributable to: |
|
|
|
Equity shareholders |
(27,221) |
(986,287) |
|
Loss per share (pence) - basic and diluted |
(0.03) |
(1.03) |
Consolidated Statement of Changes in Shareholders' Equity
For the year ended
|
|
Attributable to Equity Shareholders - Group |
||||
|
|
Share capital £ |
Share premium £ |
Other reserves £ |
Accumulated losses £ |
Total equity £ |
|
As at |
957,100 |
1,225,507 |
181,540 |
(914,079) |
1,450,068 |
|
Loss for the year |
- |
- |
- |
(986,287) |
(986,287) |
|
Total comprehensive loss for the year |
- |
- |
- |
(986,287) |
(986,287) |
|
As at |
957,100 |
1,225,507 |
181,540 |
(1,900,366) |
463,781 |
|
As at |
957,100 |
1,225,507 |
181,540 |
(1,900,366) |
463,781 |
|
Loss for the year |
- |
- |
- |
(27,221) |
(27,221) |
|
Total comprehensive loss for the year |
- |
- |
- |
(27,221) |
(27,221) |
|
Transactions with owners |
|
|
|
|
|
|
Warrants expired |
- |
- |
(26,916) |
26,916 |
- |
|
Total transactions with owners |
- |
- |
(26,916) |
26,916 |
- |
|
As at |
957,100 |
1,225,507 |
154,624 |
(1,900,671) |
436,560 |
Consolidated Statement of Changes in Shareholders' Equity
As at
|
|
Share capital £ |
Share premium £ |
Other reserves £ |
Accumulated losses £ |
Total equity £ |
|
As at |
957,100 |
1,225,507 |
181,540 |
(1,033,344) |
1,330,803 |
|
Loss for the year |
- |
- |
- |
(861,792) |
(861,792) |
|
Total comprehensive loss for the year |
- |
- |
- |
(861,792) |
(861,792) |
|
As at |
957,100 |
1,225,507 |
181,540 |
(1,895,136) |
469,011 |
|
|
|
|
|
|
|
|
As at |
957,100 |
1,225,507 |
181,540 |
(1,895,136) |
469,011 |
|
Loss for the year |
- |
- |
- |
(130,371) |
(130,371) |
|
Total comprehensive loss for the year |
- |
- |
- |
(130,371) |
(130,371) |
|
Transactions with owners |
|
|
|
|
|
|
Warrants expired |
- |
- |
(26,916) |
26,916 |
- |
|
Transactions with owners |
- |
- |
(26,916) |
26,916 |
- |
|
As at |
957,100 |
1,225,507 |
154,624 |
(1,998,591) |
338,640 |
Consolidated and Company Statement of Cash Flows
|
|
Group |
Company |
|
||
|
|
Year ended |
Year ended |
Year ended |
Year ended |
|
|
Cash flows from operating activities |
|
|
|
|
|
|
Loss after taxation |
(27,221) |
(986,287) |
(130,371) |
(861,792) |
|
|
Adjustments for: |
|
|
|
|
|
|
Depreciation & amortisation |
55,590 |
55,593 |
- |
- |
|
|
Impairment of receivables |
12,700 |
102,933 |
- |
- |
|
|
Other gains/(losses) |
(10,300) |
|
(13,694) |
|
|
|
Fair value loss/(gain) on fair value through profit and loss equity investments |
67,355 |
63,006 |
82,817 |
58,698 |
|
|
Fair value gain/ loss on financial assets at fair value through profit and loss |
(120,111) |
750,000 |
(120,111) |
750,000 |
|
|
Decrease/(Increase) in trade and other receivables |
(130,375) |
(66,665) |
22,200 |
43,430 |
|
|
Increase/(decrease) in trade and other payables |
109,631 |
26,898 |
54,901 |
34,409 |
|
|
Income tax received/(paid) |
150 |
(10,135) |
- |
- |
|
|
Income tax (income)/expense |
(150) |
10,135 |
- |
- |
|
|
Net finance costs |
- |
140 |
- |
152 |
|
|
Dividend income |
- |
- |
- |
(205,887) |
|
|
Net cash used in operating activities |
(42,731) |
(54,382) |
(104,258) |
(180,990) |
|
|
Cash flows from investing activities |
|
|
|
|
|
|
Cash received for sale of investments |
97,536 |
- |
97,536 |
- |
|
|
Cash paid for investments |
(22,500) |
(55,014) |
(22,500) |
(55,014) |
|
|
Dividend received |
- |
- |
- |
165,000 |
|
|
Loans received |
- |
- |
27,475 |
- |
|
|
Loans granted |
- |
- |
(23,947) |
(2,112) |
|
|
Interest received |
- |
13 |
- |
- |
|
|
Net cash used in investing activities |
75,036 |
(55,001) |
78,564 |
107,874 |
|
|
Net increase in cash and cash equivalents |
32,305 |
(109,383) |
(25,694) |
(73,116) |
|
|
Cash and cash equivalents at beginning of year |
163,220 |
272,603 |
37,998 |
111,114 |
|
|
Cash and cash equivalents at end of year |
195,525 |
163,220 |
12,304 |
37,998 |
|
|
Non-Cash Investing and Financing Activities
Year ended Year ended |
|||||
Events after the Reporting Date
Post period end, the Company announced that the redemption date for the unsecured convertible loan notes in TAE was extended by mutual consent to
The Company, Miriad and
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the